Seattle Genetics' cancer drug put on clinical hold after four deaths

(Reuters) - Seattle Genetics Inc said four people had died in trials testing its experimental cancer drug, prompting the U.S. Food and Drug Administration to impose a clinical hold on several early-stage studies.